Kiwi Farma

Kiwi Farma is a specialty pharmaceutical company based in Istanbul, Turkey, that focuses on providing access to innovative treatments for rare diseases and orphan conditions. Founded in 2015, the company specializes in the licensing, registration, and commercialization of high-tech pharmaceutical products from global biotechnology partners for the Turkish market. Kiwi Farma serves as a strategic partner for international firms, managing the complex regulatory and market access requirements necessary to bring life-changing therapies to patients. Its portfolio includes advanced modalities such as enzyme replacement therapies and monoclonal antibodies for metabolic, oncological, and hematological disorders. The company is dedicated to bridging the gap between global medical innovation and patients suffering from debilitating rare diseases in the region.